While this happened, Ladenburg Thalmann initiated its Novabay Pharmaceuticals Inc [NBY] rating to a Buy in a research note published on September 18, 2019; the price target was $1.10. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in early July has reiterated a ‘”a Buy”‘ rating for it. Laidlaw also remained covering NBY and reiterated its “Buy” recommendation on November 15, 2017. ROTH Capital started covering the stock on June 05, 2017. It rated NBY as “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of NBY
On Tuesday, Novabay Pharmaceuticals Inc [AMEX:NBY] saw its stock jump 18.24% to $0.65. Over the last five days, the stock has gained 10.12%. Novabay Pharmaceuticals Inc shares have fallen nearly -90.89% since the year began. Nevertheless, the stocks have fallen -94.64% over the past one year. While a 52-week high of $12.84 was reached on 05/17/24, a 52-week low of $0.36 was recorded on 08/09/24. SMA at 50 days reached $0.5830, while 200 days put it at $2.7329.
Levels Of Support And Resistance For NBY Stock
The 24-hour chart illustrates a support level at 0.5743, which if violated will result in even more drops to 0.4977. On the upside, there is a resistance level at 0.7232. A further resistance level may holdings at 0.7955. The Relative Strength Index (RSI) on the 14-day chart is 54.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0162, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 38.10%. Stochastics %K at 25.15% indicates the stock is a holding.
How much short interest is there in Novabay Pharmaceuticals Inc?
A steep rise in short interest was recorded in Novabay Pharmaceuticals Inc stocks on 2024-10-15, dropping by -0.11 million shares to a total of 17887.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 0.13 million shares. There was a decline of -608.18%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 27, 2017 when Laidlaw began covering the stock and recommended ‘”a Buy”‘ rating along with a $10 price target.
